Comparative efficacy of 2 topical anesthetics for the placement of orthodontic temporary anchorage devices. by Reznik, Derek S et al.
Comparative Efficacy of 2 Topical Anesthetics for
the Placement of Orthodontic Temporary
Anchorage Devices
Derek S. Reznik, BS, DDS, MS,* Arthur H. Jeske, DMD, PhD, Jung-Wei Chen, DDS, MS,
PhD,` and Jeryl English, DDS, MS§
*Private Practice, Orthodontics, Odessa, Texas, Department of Restorative Dentistry & Biomaterials, University of Texas Dental Branch–
Houston, `Department of Pediatric Dentistry, Loma Linda University, and §Department of Orthodontics, University of Texas Dental Branch–
Houston
This study compared the effectiveness of topical benzocaine 20% versus a combina-
tion of lidocaine, tetracaine, and phenylephrine in providing sufficient analgesia for
the placement of orthodontic temporary anchorage devices (TADs).The 2 topical an-
esthetics were tested against each other bilaterally using a randomized, double-blind,
crossover design.The agentswere left in place for the amount of timeprescribed by the
manufacturer.TheTADwas thenplaced, andeach subject rated the degreeofpain on a
Heft-Parker visual analogue scale. A pulse oximeter was used to record the preopera-
tive and postoperative pulse rates. Statistically significant differences in perceived
pain (P, .05) and success rate (P, .01) between drugs were seen, but no significant
difference inpulse rate changebetween the topical anestheticswasobserved (P..05).
It was concluded that when the efficacy of topical benzocaine and of a combination
product was compared as the sole anesthetic to facilitate acceptable pain control for
placement of orthodontic temporary anchorage devices, the combination product
was considerablymore efficacious.
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caine; Benzocaine; Phenylephrine.
Anchorage control is fundamental to successful or-thodontic treatment. Miniscrews, or orthodontic
temporary anchorage devices (TADs), have recently
emerged as an increasingly more common means of
providing the orthodontist with intraoral absolute an-
chorage. TADs are able to be loaded immediately fol-
lowing placement, can be placed quickly and efficient-
ly, do not require a mucoperiosteal flap for placement
or removal, and can be placed by the orthodontist.1^4
Topical anesthesia has been shown to reduce the
discomfort of local anesthetic injections5^13 and some
intraoral operative procedures, including periodontal
scaling and root planing,14,15 gingival manipula-
tion,16,17 biopsy,18,19 dentinal/pulpal anesthesia,20
and dental extractions.21 Topical anesthetics have
been shown not only to reduce the perception of pain,
but to reduce patient anxiety22,23 and the possibility of
needle-stick injuries. The potential of sufficient analge-
sia from topical anesthetics for orthodontic temporary
anchorage placement has been suggested in the litera-
ture4,24 and would offer a major advantage to the cli-
nician and the patient; however, no studies to date
have been performed to compare topical anesthetic
agents for this purpose.
The goal of this research project was to determine
the comparative efficacy of 2 topical anesthetics for
the placement of orthodonticTADs, thus giving the cli-
nician an efficient, nonpainful technique for TAD
placement, while providing minimal psychological
and physiologic stress to the patient.
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Seventeen adolescent and adult subjects, 8 males and 9
females aged12 to 76 years, who were patients of record
at theUniversity ofTexas Health ScienceCenter at Hous-
ton Dental Branch Orthodontic Clinic and requiredTAD
placement bilaterally for space closure, space mainte-
nance, or intrusion or extrusion of teeth were included in
this double-blind, prospective study. Exclusion criteria
included allergy or other contraindication to any study
medication, inability to consent to participation in the
study, use of analgesics prior to the procedure, history of
cardiovascular disease, and any contraindication to the
use ofTADs.TheUniversity ofTexas Health ScienceCen-
ter atHoustonHumanSubjectsCommittee approved this
study as protocol HSC-DB-07-0006, and written in-
formed consent was obtained from each subject and, if
applicable, the subject’s guardian.
A random number table was used to determine
which topical anesthetic was to be used first on each
subject for the open-label study. The second anchor
was placed after a washout period of at least 5 days,
and the comparator drug utilized at the second visit.
TADs used were the Quattro temporary anchorage
devices from the Mondeal Orthodontic Anchorage
System (GAC International Inc, Bohemia, NY). Quat-
tro temporary anchorage devices are self-drilling, self-
tapping, polished titanium screws with a tube and slot
on the head, which allow for 3-dimensional edgewise
control. The threaded portion of the TAD is 1.5 mm in
diameter and 7 mm in length (Figure 1). Placement of
the anchor is initiated in the mucosa by simply insert-
ing theTAD through the gingival or alveolar mucosa to
the periosteum, using a manual driver. All TADs were
placed by the same, blinded orthodontist.
Prior to placement of theTADs, a preoperative pulse
rate was determined with a pulse oximeter (Comfort
Cuff 506N3, Criticare Systems Inc,Waukesha,Wis) af-
ter the subject was allowed to sit in the dental chair for
10 minutes. Subjects were familiarized with the use of
a Heft-Parker visual analogue scale25 (VAS) pain as-
sessment instrument at the placement appointment.
A baseline VAS score was taken preoperatively to
quantitatively ensure that subjects were not in pain
prior to the procedure, and to obtain information on
the comparability/consistency of pain evaluations
across the 2 groups. Pulse rate was continuously mon-
itored for 30 minutes, because discomfort-related
tachycardia will likely occur very early upon or shortly
after beginning theTAD placement procedure.
The TAD placement site was marked with an intra-
oral dye marker. One of the 2 study drugsI20% ben-
zocaine gel (HurriCaine Topical Anesthetic GEL, Beu-
tlich LP Pharmaceuticals, Waukegan, Ill ) or a combi-
nation product containing lidocaine 20%, tetracaine
4%, and phenylephrine 2% (TAC 20% Alternate Top-
ical Anesthetic Gel Thick, Professional Arts Pharmacy,
Lafayette, La)Iwas applied on the attached gingiva or
alveolar mucosa overlying the intended anchorage site
using a cotton-tipped applicator and was allowed to
remain in contact with the tissue for the amount of
time prescribed by the manufacturer (1.0 and 2.5 min-
utes, respectively). To blind the subject, goggles were
placed over the patient’s eyes while the anesthetic
was applied. Placement of the TAD was then accom-
plished by a different orthodontist, who did not know
which topical anesthetic preparation was utilized. All
TADs were placed by the same, blinded orthodontist.
The maximum postoperative pulse rate in beats per
minute (BPM) observed within 30 minutes was re-
corded to be used in the experimental comparison
with preoperative values. Subjects rated the pain of
TAD placement on the postoperativeVAS immediately
Figure 1. Diagram of Quattro temporary intraosseous or-
thodontic anchorage device (GAC International Inc ) (en-
largement approximately 133).
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after each placement procedure was completed. VAS
and pulse rate data were analyzed by a blinded, inde-
pendent evaluator.
In the event the subject did not tolerate placement of
the orthodontic temporary anchorage device because of
pain greater than mild at any time, the procedure was in-
terrupted, the subject completed theVAS form, and the
study drug was rated as a failure. A standard amide local
anesthetic (2% lidocaine with 1 : 100,000 epinephrine)
was then injected by infiltration, and the TAD placed.
Subjects were monitored in the postoperative period for
1 day for the occurrence of pain and/or other complica-
tions, and appropriate analgesics and/or other interven-
tions were provided as necessary.
Age, gender, study drug, preoperative and postoper-
ative VAS scores, preoperative pulse rate in BPM, and
maximum postoperative pulse rate in BPM data were
recorded, and descriptive statistics calculated for each
variable. The difference between maximum postopera-
tive and preoperative pulse rates was calculated, as
was the difference divided by the preoperative pulse
rate (percent pulse rate change). A paired t test was
utilized to compare the 2 study drugs from the sub-
jects (n 5 17) in which 2 TADs were placedI1 with
each study drug for both VAS and percent pulse rate
change. A Pearson chi-square test was utilized to com-
pare the success rates of the 2 study drugs. The statis-
tical significance level was set at P , .05.
RESULTS
Seventeen subjects, 8 males and 9 females aged 12 to
76 years, had TADs placed bilaterally, 1 with each
study drug for a total of 34 study drug applications,
17 for each study drug. Subject demographics are
shown in Table 1.
Table 2 shows the mean VAS, preoperative and
postoperative pulse rates, pulse difference, percent
pulse rate change, and percent success and failure for
the benzocaine and combination topical groups.
A lower rating on the VAS score signifies less pain
perception. The mean pain rating for the benzocaine
group was 92.71 6 46.14 SD. The mean pain rating
for the TAC group was 33.12 6 32.20 SD. The paired
t test demonstrated a significant difference (P , .05) in
perceived pain values between anesthetic groups. The
combination topical group had significantly lower per-
ceived pain values than the benzocaine group.
A smaller percent change signifies a smaller physiolog-
ic response to the experimental stimulus.The mean per-
centpulserate change in thebenzocainegroupwas1465
SD, and for the combination topical group, themean per-
cent pulse rate change was14 612 SD.The paired t test
did not indicate a significant difference (P..05) between
groups for percent pulse rate change. No adverse events
were observed in either group.
The Pearson chi-square analysis demonstrated a
significant difference (P , .01) between groups for suc-
cess rate, with TAC exhibiting a significantly higher
success rate than benzocaine.
The independent t test demonstrated no difference
(P . .05) in pain rating or percent pulse rate change
between genders. Pearson correlation demonstrated
no correlation (P . .05) between age and pain rating
or percent pulse rate change.
DISCUSSION
Results of this study indicate that the placement of or-
thodontic temporary anchorage devices is well tolerat-




Age range, y 12^76
Average age, y 27.18
Table 2. MeanVAS Scores, Preoperative and Postoperative Pulse Rates, Pulse Difference and Percent Pulse Rate Change, and
Success and Failure Rates of Benzocaine and a Combination of Lidocaine,Tetracaine, and Phenylephrine
Benzocaine Combination
VAS scoresa 92.71 646.14* 33.12 632.20*
Preoperative pulse rate 78.06 75.5
Postoperative pulse rate 88.41 85.2
Pulse differencea 10.35 6 4.05 9.94 67.74
Percent pulse rate changea 14 65 14 612
Success rate 29%** 100%**
Failure rate 71%** 0%**
a Values are given as mean 6 standard deviation.
* Indicates a significant difference (P,.05).
** Indicates a significant difference (P,.01).
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100% success rate and the significantly (P , .05) low-
er pain rating for theTAC group, compared with only a
29% success rate and higher pain ratings for the ben-
zocaine group, indicate that subjects experienced less
pain when TAC was used instead of benzocaine. How-
ever, the lack of a significant difference (P . .05) in
percent pulse rate change suggests that the difference
in pain levels experienced was not dramatic enough to
elicit a different physiologic response.
This apparent anomaly could be due to the fact that
benzocaine was rated as a failure 71% of the time, and
this occurred most often shortly after the procedure
began. Therefore, as dictated by protocol, the proce-
dure was interrupted, 2% lidocaine with 1 : 100,000
epinephrine was infiltrated, and the TAD was placed.
We suspect that if the procedure had been completed
without the infiltration of anesthetic, a marked in-
crease in pulse rate could have occurred, and a signif-
icant difference in pulse rate change between study
drug groups might have been observed.
The difference in success rates andpain ratings between
TAC and benzocaine could be anticipated owing to the
presence of both an ester (tetracaine) and an amide (lido-
caine) anesthetic as well as a vasoconstrictor (phenyleph-
rine) inTAC. Several studies have been performed to com-
pare mixtures of topical anesthetics, most commonly
EMLA (2.5% lidocaineand2.5%prilocaine),versus single
anesthetic agents. Both McMillan et al.16 and Donaldson
andMeechan17 found EMLA to be amore effective topical
anesthetic agent than 5% lidocaine gel for minor manipu-
lations of the gingiva.Tulga andMutlu,7 on the other hand,
found20%benzocainegel tobemoreeffective thanEMLA
cream in reducing intraoral injection pain; although it was
the authors’perception that the chocolate flavorof the ben-
zocaine gel used impressed the patients, who were com-
posed entirely of 120 children aged 10 to 15 years, com-
paredwith the unpleasant taste of the EMLAcream.7
Although generally regarded as equivalent in effica-
cy to 20% benzocaine, 5% lidocaine was not evaluat-
ed in the present study.
The low success rate of benzocaine could be due to
the location of the TAD placement. Nakanishi et al.12
found that when topical anesthetic was applied in the
mucobuccal fold of the anterior mandible, a reduction
in pain from needle insertion resulted, although no
difference from placebo was found when it was ap-
plied in the pterygotemporal depression. Nusstein
and Beck13 similarly reported that 20% benzocaine
lacked effectiveness in reducing pain from needle in-
sertion in the pterygomandibular raphe for an inferior
alveolar nerve block, as well as over the maxillary first
molars, even though benzocaine was beneficial in re-
ducing needle insertion pain over the maxillary lateral
incisors.
Meechan6 emphasized that the importance of loca-
tion in determining topical anesthetic efficacy related
to factors such as tissue type (e.g., keratinized vs non-
keratinized mucosa) and the depth at which the nox-
ious event occurs (e.g., superficial infiltration vs a
deeper regional block). Therefore, benzocaine might
have a higher success rate if used prior to TAD place-
ment in areas of thin, nonkeratinized mucosa, or in the
mucobuccal fold of the anterior mandible or maxilla.
For this study, all TADs were placed in the attached
or unattached buccal mucosa of the maxilla or mandi-
ble, but information on mucosal type, thickness, and
specific location was not collected. For this reason, fu-
ture research is needed to determine whether the effi-
cacy of topical anesthetic agents for TAD placement is
related to tissue type, thickness, or location of place-
ment.
Although anesthesia of the periosteum and cortical
bone is not predictable with topical anesthetics, the
brevity of the temporary anchorage device placement
technique may have minimized discomfort resulting
from stimulation of these tissues. Therefore, future re-
search is needed to compare the use of TAC topical
anesthetic versus traditional injection anesthesia for
TAD placement. Safety issues related to combination
topical anesthetics also require further investigation.26
The 100% success rate of TAC topical anesthetic may
not be observed with a larger population owing to var-
iations in TAD placement location, topical anesthetic
application time, and interoperator variability.
The use of a topical anesthetic as the sole means of
analgesia for placement of orthodontic temporary an-
chorage devices has been demonstrated, and TAC was
shown to significantly (P , .05) decrease pain ratings
when compared with 20% benzocaine, and to have a
significantly (P , .01) higher success rate (100%) com-
pared with benzocaine (29%). When the efficacy of
topical benzocaine is compared with that of TAC as
the sole anesthetic to facilitate acceptable pain control
for placement of orthodontic temporary anchorage de-
vices,TAC was found to be more efficacious.
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